During the past decade, BIAL - Portela & Cª, S.A. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 10 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "BIAL - Portela & Cª, S.A." are "Parkinson Disease" (6 trials), "Epilepsy" (4 trials), "Parkinson's Disease" (2 trials), "Parkinson's Disease (PD)" (2 trials) and "Partial Epilepsy" (2 trials). Many other conditions were trialed in "BIAL - Portela & Cª, S.A." in a lesser frequency.

Most popular intervention types in "BIAL - Portela & Cª, S.A." are "Drug" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "BIA 9-1067" (5 trials), "BIA 2-093" (3 trials), "BIA 6-512" (3 trials) and "eslicarbazepine acetate" (3 trials). Other intervention names were less common.

The vast majority of trials in "BIAL - Portela & Cª, S.A." are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "BIAL - Portela & Cª, S.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in BIAL - Portela & Cª, S.A., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in BIAL - Portela & Cª, S.A., 10 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".